Freie Erde

Wiley and German DEAL Consortium to Sign New 5-Year Agreement

Retrieved on: 
Thursday, October 19, 2023

Wiley (NYSE: WLY) today announced its intent to enter a new five-year agreement with the DEAL Consortium, a countrywide consortium representative of more than 1,000 academic institutions in Germany, commencing January 2024.

Key Points: 
  • Wiley (NYSE: WLY) today announced its intent to enter a new five-year agreement with the DEAL Consortium, a countrywide consortium representative of more than 1,000 academic institutions in Germany, commencing January 2024.
  • Wiley and DEAL are creating a blueprint for the next phase of open access publishing to better meet the evolving needs of the scholarly community.
  • Wiley was the first publisher to sign an agreement with DEAL, which makes this partnership the most robust and long-lasting in Germany.
  • Their new agreement will continue to provide authors at German institutions with open access publishing options across Wiley’s portfolio.

The DEAL Consortium and Elsevier Announce Transformative Open Access Agreement for Germany

Retrieved on: 
Wednesday, September 6, 2023

Berlin, Germany--(Newsfile Corp. - September 6, 2023) - The DEAL Consortium , representing the German research institutions, and Elsevier , a global leader in scientific information and data analytics, are delighted to announce a transformative open access agreement for Germany.

Key Points: 
  • Berlin, Germany--(Newsfile Corp. - September 6, 2023) - The DEAL Consortium , representing the German research institutions, and Elsevier , a global leader in scientific information and data analytics, are delighted to announce a transformative open access agreement for Germany.
  • In addition, institutions will receive discounts on the list prices for their researchers' publications in fully open access Elsevier journals.
  • The agreement fulfils the key objectives set out by the Alliance of Science Organizations in Germany for the DEAL negotiations in enabling open access publishing and reading across Elsevier’s portfolio.
  • The DEAL Consortium and Elsevier worked together collaboratively and pragmatically to support Germany’s world-leading academic and science organizations achieve their research goals for the benefit of society.